METHODS FOR DETERMINING PATIENT'S SUSCEPTIBILITY TO NOSOCOMIAL INFECTION AND PREDICTING DEVELOPMENT OF A SEPTIC SYNDROME Russian patent published in 2018 - IPC C12Q1/6809 

Abstract RU 2663724 C2

FIELD: biotechnology.

SUBSTANCE: invention relates to biotechnology, namely to prognosis of development of a septic syndrome in a patient, and can be used in medicine. Biological sample is obtained from a sample of blood, serum, saliva, tissue or circulating cells of the patient is obtained and the biological material is extracted: a nucleic acid or a protein from a biological sample. Reagent specific to a S100A9 target gene expression product specified in an amplification primer, a hybridization probe and/or antibody is used to determine S100A9 target gene expression.

EFFECT: invention allows to make the prognosis of development of a septic syndrome in a patient by overexpression of the target gene S100A9 in relation to a certain threshold value.

9 cl, 2 dwg, 3 tbl, 5 ex

Similar patents RU2663724C2

Title Year Author Number
METHODS FOR PATIENT'S RESPONSE TO HOSPITAL INFECTION TEST AND FORECASTING OF DEVELOPING SEPSIS SYNDROME 2010
  • Kazali Mari-Anzhelik
  • Lepap Alen
  • Monnere Gijom
  • Muzhen Brjuno
  • Pasho Aleksandr
RU2525707C2
IDENTIFICATION OF TUMOUR-ASSOCIATED ANTIGENS FOR DIAGNOSTICS AND THERAPY 2013
  • Sakhin Ugur
  • Tyurechi Ezlem
  • Kozlovski Mikhael
  • Uzener Dirk
RU2644686C2
METHOD OF DIAGNOSING NEOPLASM-II 2008
  • Lapuant Lourens S.
  • Danne Robert
  • Jang Grem P.
  • Lokett Trevor Dzhon
  • Uilson Uil'Jam Dzh.
  • Mollou Piter Lorans
RU2565540C2
TREATMENT OF SODIUM CHANNEL, VOLTAGE-GATED, ALPHA SUBUNIT (SCNA) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SCNA 2011
  • Kollard Dzhozef
  • Khorkova Sherman Olga
  • De Leon Belinda
  • Kojto Karlos
  • Khsyao Dzhejn Kh., Dr.
RU2588654C2
METHODS AND KITS FOR MOLECULAR SUBTYPING OF TUMORS 2014
  • Virtts Ralf
  • Knajp Kristof
RU2690241C2
METHODS AND COMPOSITIONS RELATED TO FUSION OF ALPHA-LINOLENIC ACID FOR PURPOSES OF CANCER DETECTION AND TREATMENT 2010
  • Nikolz Dzhosh
  • Dal'Khauzer Ehrik
  • Khaut Dehvid
  • Norman Kim
RU2562144C2
DIAGNOSTIC TECHNIQUE FOR BLADDER CANCER (VERSIONS) AND KIT FOR IMPLEMENTATION THEREOF 2011
  • Zabolotneva Anastasija Aleksandrovna
  • Shegaj Petr Viktorovich
  • Gajfullin Nurshat Minullaevich
  • Rusakov Igor' Georgievich
  • Alekseev Boris Jakovlevich
  • Buzdin Anton Aleksandrovich
RU2469323C2
MULTIPARAMETRIC DIAGNOSTIC TEST SYSTEM FOR QUANTITATIVE DETERMINATION OF MRNA LEVEL OF HUMAN RIG-1, IFIT-1, IFIH-1 GENES 2021
  • Vasin Andrei Vladimirovich
  • Giulikhandanova Nataliia Evgenevna
  • Lozhkov Aleksei Aleksandrovich
  • Klotchenko Sergei Anatolevich
  • Plotnikova Marina Aleksandrovna
RU2782428C1
QUANTIFICATION OF THE hsa-miR-30c-5/VIM, hsa-miR-28-3p/VIM, hsa-miR-1-3p/ANXA2, hsa-miR-30c-5p/FBN1, hsa-miR-15b-5p/MYL6 tr.v.1, hsa-miR-15b-5p/MYL6 tr.v.2, hsa-miR-185-3p/FLNA, hsa-miR-1-3p/YWHAZ, hsa-miR-30c-5p/YWHAZ AND hsa-miR-654-3p/FGA RATIO IN THE PLACENTAL SITE OF WOMEN ON THE DAY OF DELIVERY AT A TERM OF MORE THAN 34 WEEKS OF GESTATION AS A METHOD FOR DIFFERENTIAL DIAGNOSIS OF FETAL GROWTH RESTRICTION SYNDROME, PREECLAMPSIA AND A SMALL FOR GESTATIONAL AGE FETUS SYNDROME 2021
  • Timofeeva Anzhelika Vladimirovna
  • Fedorov Ivan Sergeevich
  • Chagovets Vitalij Viktorovich
  • Starodubtseva Nataliya Leonidovna
  • Frankevich Vladimir Evgenevich
  • Shmakov Roman Georgievich
  • Sukhikh Gennadij Tikhonovich
RU2771205C1
DIAGNOSTIC TECHNIQUE FOR BLADDER CANCER BY CANCER-SPECIFIC MARKER TEDP1 (VERSIONS) AND KIT FOR IMPLEMENTING IT 2011
  • Zabolotneva Anastasija Aleksandrovna
  • Shegaj Petr Viktorovich
  • Gajfullin Nurshat Minullaevich
  • Rusakov Igor' Georgievich
  • Alekseev Boris Jakovlevich
  • Buzdin Anton Aleksandrovich
RU2463354C1

RU 2 663 724 C2

Authors

Kazali Mari-Anzhelik

Lepap Alen

Monnere Gijom

Muzhen Bryuno

Pasho Aleksandr

Dates

2018-08-08Published

2014-06-03Filed